Serum sickness following rituximab therapy in multiple sclerosis
نویسندگان
چکیده
منابع مشابه
Rituximab in multiple sclerosis
OBJECTIVE To investigate the safety and efficacy of rituximab in multiple sclerosis (MS). METHODS In this retrospective uncontrolled observational multicenter study, off-label rituximab-treated patients with MS were identified through the Swedish MS register. Outcome data were collected from the MS register and medical charts. Adverse events (AEs) grades 2-5 according to the Common Terminolog...
متن کاملFulminant Colitis Following Rituximab Therapy.
Rituximab (RTX; Rituxan, Genentech) is the clinical formulation of a murine immunoglobulin G (IgG) 1 monoclonal anti-CD20 antibody and is widely used in the initial treatment of CD20-positive hematologic malignancies and a variety of autoimmune disorders. Rarely, fulminant colitis has been reported with the use of RTX (Table).1-7 We report a patient who developed 2 episodes of fulminant colitis...
متن کاملReduction of Saliva and Serum 25-Hydroxycholecalciferol in Multiple Sclerosis
Methods: The prevalence of multiple sclerosis (MS) is high in patients suffering from 25-hydroxyvitamin D3 [25(OH)D] deficiency. The aim of this study was to investigate the possible association of saliva and serum 25(OH)D concentrations with MS in women.Methods: Serum and saliva 25(OH)D levels of 30 MS women and 30 matched healthy controls in this case-control study were measured by ELIS...
متن کاملSerum Bilirubin Level Changes in Multiple Sclerosis Patients
Background: Multiple Sclerosis (MS) is a demyelinating disorder of the Central Nervous System (CNS). In addition to the role of immune mediated mechanisms, oxidative and nitrosative stress also play an important role in neuropathology of MS. Bilirubin as an endogenous antioxidant has neuroprotective effects; however few studies have assessed the association between serum bilirubin level and MS....
متن کاملP 151: Clinical Trial in Cell Therapy of Multiple Sclerosis
Neuroinflammation is a disorder that causes neurological disease. Neuroinflammation has a significant role in induce of Multiple sclerosis (MS) and one of the situations that must be treated stops the ongoing process of inflammation against the CNS by self-reactive lymphocytes. According to the successful results that were obtained from the pre-clinical phase of cell therapy, many studies were ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neurology: Clinical Practice
سال: 2019
ISSN: 2163-0402,2163-0933
DOI: 10.1212/cpj.0000000000000685